SCHEMBL12338615

SCHEMBL12338615

Cc1ccc(CNc2ccc(Cc3c[nH]c4ncc(OCCN5CCCC5)cc34)cn2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 3/20 0.57
▸ CYP2C19 P33261 5/20 0.52
▸ CYP3A4 P08684 11/20 0.49
▸ CYP2D6 P10635 1/20 0.48
▸ KIT P10721 2/20 0.46
▸ LCK P06239 1/20 0.46
▸ PGR P06401 1/20 0.46
▸ CHRM2 P08172 1/20 0.46
▸ HTR1A P08908 1/20 0.46
▸ ADRA2A P08913 1/20 0.46
▸ PDGFRB P09619 1/20 0.46
▸ ADORA3 P0DMS8 1/20 0.46
▸ CHRM1 P11229 1/20 0.46
▸ PDGFRA P16234 1/20 0.46
▸ FLT1 P17948 1/20 0.46
▸ DRD1 P21728 1/20 0.46
▸ TBXA2R P21731 1/20 0.46
▸ SLC6A2 P23975 1/20 0.46
▸ ADORA1 P30542 1/20 0.46
▸ SLC6A4 P31645 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1267604 0.89 CSF1R (0.71) CSF1RCYP2C19CYP3A4CYP2D6KIT
SCHEMBL15316826 0.85 LTA4H (0.42) CSF1RCYP2C19CYP3A4CYP2D6HTR1A
SCHEMBL12338611 0.84 CSF1R (0.40) CSF1RCYP2C19KITDRD1CYP1A2
SCHEMBL1267483 0.84 CYP3A4 (0.54) CSF1RCYP2C19CYP3A4CYP2D6KIT
SCHEMBL12338612 0.84 CSF1R (0.41) CSF1RCYP2C19CYP3A4KITCYP1A2
SCHEMBL21304793 0.82 CSF1R (0.59) CSF1RCYP2C19CYP3A4CYP2D6KIT
SCHEMBL1267328 0.82 CSF1R (0.68) CSF1RCYP2C19CYP3A4CYP2D6KIT
SCHEMBL19302326 0.82 CSF1R (0.58) CSF1RCYP2C19CYP3A4CYP2D6KIT
SCHEMBL15316822 0.78 CYP3A4 (0.44) CSF1RCYP2C19CYP3A4KITCYP2C9
SCHEMBL14197571 0.78 NTRK1 (0.45) CSF1RCYP2C19CYP3A4KITDRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8268858-B2 e.g. 5-(3-methoxybenzyloxy)-1H-pyrrolo[2,3-b]pyridine; protein kinases inhibitor; central nervous system disorders; Alzheimer's disease; Parkinson's disease; anticancer, antitumor agents; analgesics; cogestive heart failure; skin disorders; inflammatory bowel disorders; transplant rejection PLEXXIKON INC. (US) 2012-09-18 — — US disclosed
Send feedback